承董事會命 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚賴該等內 容而引致的任何損失承擔任何責任。 眾安在綫財產保險股份有限公司 ZHONGAN ONLINE P & C INSURANCE CO., LTD.* （於中華人民共和國註冊成立的股份有限公司，並以「ZA Online Fintech P & C」在香港經營業務） （股份代號：6060） 關於保費收入的公告 眾安在綫財產保險股份有限公司（「本公司」）於2025年1月1日至2025年12月31日 所獲得的原保險保費收入總額約為人民幣35,643百萬元。上述資料按照中華人民共 和國財政部《企業會計準則第25號－原保險合同》（財會[2006]3號）及《保險合同相關 會計處理規定》（財會[2009]15號）編製，未經審核及未經本公司審計與消費者權益 保護委員會審閱。本公司股東及潛在投資者務須審慎，以免不恰當依賴該等資料。 眾安在綫財產保險股份有限公司 董事長 尹海 中國上海，2026年1月15日 於本公告日期，本公司董事會包括兩名執行董 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內 容而引致的任何損失承擔任何責任。 眾安在綫財產保險股份有限公司 ZHONGAN ONLINE P & C INSURANCE CO., LTD.* （於中華人民共和國註冊成立的股份有限公司，並以「ZA Online Fintech P & C」在香港經營業務） （股份代號：6060） （「第 二 批 票 據」，連 同 首 批 票 據 統 稱「票 據 」） （ 票 據 代 號：40369） 完成贖回票據 （「發行人」） (I) 300,000,000 美元於 2026 年到期的 3.50% 票 據（「 首 批 票 據 」）； 及 (II) 1 00,000,000 美元於 2026 年到期的 3.50% 票 據 （與首批票據合併並形成單一系列） 於完成贖回票據後，概無發行在外的票據。發行人已向香港聯合交易所有限公司申 請撤銷票據的上市地位。有關撤銷上市地位預期將於2026年1月21日營業時間結束 後生效。 香港，2026年1月13日 茲提 ...

Group 1 - The core point of the news is that ZhongAn Online P&C Insurance Co., Ltd. has applied for a patent for a method and device for fine-grained image classification, indicating its focus on technological innovation in the insurance sector [1] - The patent application, published as CN121305216A, was filed on October 2025 and describes a method that includes processing target images to obtain feature sequences and using an attention mechanism for classification tasks [1] - ZhongAn Online was established in 2013 and is based in Shanghai, with a registered capital of 1,469.81 million RMB, highlighting its significant financial foundation [1] Group 2 - The company has made investments in 5 enterprises and participated in 90 bidding projects, showcasing its active engagement in the market [1] - ZhongAn Online holds 447 trademark registrations and 112 patent registrations, indicating a strong intellectual property portfolio [1] - The company also possesses 5 administrative licenses, reflecting its compliance and operational capabilities within the insurance industry [1]

Core Viewpoint - Hong Kong Exchanges and Clearing Limited officially launched the "Hong Kong Stock Exchange Technology 100 Index" on December 9, 2025, with ZhongAn Online P&C Insurance Co., Ltd. being selected as one of the first constituent stocks due to its strong technological attributes and innovation capabilities [1] Group 1: Company Highlights - ZhongAn's inclusion in the index reflects market recognition of its significant investments and achievements in technology over the years [1] - In the first half of 2025, ZhongAn's self-developed "Zhongyou Lingxi" AI platform supported nearly 110 robots in business applications, with a cumulative call volume of 450 million [1] - The use of AI image recognition technology in claims processing has increased the intelligent review approval rate of health insurance claims materials to 90%, enabling case closures in as fast as 15 seconds [1] Group 2: Industry Context - The "Hong Kong Stock Exchange Technology 100 Index" aims to track the 100 largest technology companies listed on the Hong Kong Stock Exchange [1] - The index employs strict selection criteria covering six major innovation themes: artificial intelligence, biotechnology and pharmaceuticals, electric vehicles and smart driving, information technology, internet, and robotics [1] - This index is designed to meet the diversified allocation needs of global and mainland Chinese investors [1]

Core Viewpoint - Zhong An Xin Ke (Shenzhen) Co., Ltd. has officially submitted its IPO application to the Hong Kong Stock Exchange, aiming to raise capital for its enterprise-level AI solutions focused on intelligent marketing and operations management [3]. Company Overview - Zhong An Xin Ke was established in December 2021 and specializes in providing enterprise-level AI solutions, particularly in intelligent marketing and operations management [3]. - The company ranks fourth among enterprise-level AI solution providers in China with vertical large model capabilities, based on projected revenues for 2024 [3]. Financial Performance - For the fiscal year ending December 31, 2023, Zhong An Xin Ke reported revenues of RMB 225.864 million, with a gross profit of RMB 30.924 million and a net profit of RMB 10.082 million [4]. - Projected revenues for 2024 and 2025 are RMB 308.532 million and RMB 290.421 million, respectively, with corresponding gross profits of RMB 83.984 million and RMB 118.367 million [4]. - The company’s net profit for the first nine months of 2024 is projected to be RMB 33.231 million, showing a significant increase compared to the previous year [4]. Shareholding Structure - Prior to the IPO, the controlling shareholder, Zhong Xing You Mi, along with other entities, holds approximately 38.93% of the voting rights in the company [7]. - Zhong An Technology, a wholly-owned subsidiary of Zhong An Online, is the second-largest shareholder with a 35.49% stake [7]. Management Team - The founding team includes Yu Feng, Zhou Zhengyu, Mao Yifeng, Wang Min, and Niu Chenghao, all of whom have backgrounds in Zhong An Online and its subsidiaries [5]. - Yu Feng serves as the Executive Director and CEO, overseeing the company's strategic planning and operations [8]. - Mao Yifeng is the Technical Director and Vice President, responsible for product development and technology [9]. - Zhou Zhengyu holds the position of Executive Director and CFO, focusing on financial planning and board operations [10].

Core Insights - The company ZhongAn Xinke has submitted its IPO application to the Hong Kong Stock Exchange, backed by ICBC International and Guolian Securities International [2] - Founded in late 2021, the company has rapidly expanded its presence in the domestic vertical large model AI solution provider market, focusing on intelligent marketing and intelligent operations [2] - The company aims to transition from being an "in-house enterprise" within the ZhongAn ecosystem to an independent market-oriented AI service provider [5] Business Performance - In 2023, the company's revenue reached 226 million yuan, projected to increase to 309 million yuan in 2024, with 290 million yuan achieved in the first nine months of 2025 [5] - Net profit rose from 10.08 million yuan in 2023 to 31.65 million yuan in 2024, indicating a significant improvement in gross margin and maturity of the business model [5] - By 2024, the company ranks fourth among enterprise-level AI service providers equipped with vertical large model capabilities in China [5] Client Dependency - The company shows a notable reliance on related parties, with its largest client, ZhongAn Group, contributing nearly 45% of revenue in 2023 and 2024, although this dropped to 23% in the first three quarters of 2025 [5] - The top five clients collectively account for nearly half of the company's revenue, highlighting the concentration risk [5] - ZhongAn Group appears on both the client and supplier lists, indicating significant related-party transactions [5] Shareholding Structure - The "ZhongAn system" is evident in the shareholding structure, with the founding team controlling approximately 38.93% of voting rights through a concerted action agreement prior to the IPO [5] - ZhongAn Technology, a wholly-owned subsidiary of ZhongAn Online, holds 35.49% of the shares, making it the second-largest shareholder [5] - The founding team has a strong background in insurance technology and digitalization, stemming from their experience within the ZhongAn Online ecosystem [5]

Core Viewpoint - ZhongAn Online is actively participating in the integration pilot of "medical insurance + commercial insurance" in Shanghai, aiming to enhance health coverage and meet the health management needs of insured individuals and their families [1][2]. Group 1: Product Offerings - The "Zhongminbao" series products, including "Zhongminbao Million Medical Insurance 2025" and "Zhongminbao High-end Medical Insurance," have been included in the personal account payment scope of Shanghai's medical insurance [1]. - The "Zhongminbao" series features "coverage for pre-existing conditions," making it more inclusive for high-risk groups such as the elderly and those with health abnormalities [1]. - The "Zhongminbao High-end Medical Insurance" has gained popularity, generating over 140 million in premiums within ten days of its launch [1]. Group 2: Coverage and Benefits - "Zhongminbao Million Medical Insurance 2025" offers low entry barriers and high coverage, with a maximum coverage amount of 6 million, covering both in-network and out-of-network medical expenses [1][2]. - The "Zhongminbao High-end Medical Insurance" provides zero deductible for inpatient medical expenses and expands the scope of critical illness treatment to include special departments in public hospitals, catering to the demand for quality medical resources [2]. Group 3: Policy Alignment and Market Impact - The integration of "Zhongminbao" into the medical insurance personal account payment system revitalizes dormant funds, transforming small amounts into significant health protection [2]. - The initiative supports family members of insured individuals, allowing them to use personal account balances for insurance, thereby enhancing family-based health risk management [4]. - ZhongAn Online has served over 100 million users in the health insurance sector, contributing to the promotion of inclusive insurance solutions and aligning with national strategies for a multi-tiered medical security system [4].

Core Viewpoint - ZhongAn Online is actively participating in the integration pilot of "Medical Insurance + Commercial Insurance" in Shanghai, aiming to enhance health coverage and meet the health management needs of insured individuals and their families [1][5]. Group 1: Product Offerings - The "Zhongminbao" series products, including "Zhongminbao Million Medical Insurance 2025" and "Zhongminbao High-end Medical Insurance," have been included in the personal account payment scope of Shanghai's medical insurance [1]. - The "Zhongminbao" series features "coverage for pre-existing conditions," making it more inclusive for high-risk groups such as the elderly and those with health issues, compared to traditional million medical insurance [1]. - The "Zhongminbao High-end Medical Insurance" offers zero deductible for inpatient medical expenses and expands the coverage for critical illness treatment to special departments in public hospitals, catering to the demand for quality medical resources [2]. Group 2: Policy and Market Impact - The integration of "Zhongminbao" into the medical insurance personal account payment system revitalizes dormant funds in personal accounts, transforming small amounts into significant health protection [2]. - The company supports insured individuals in using their personal account balances to cover family members, promoting a family-oriented health risk defense strategy [4]. - The initiative aligns with national strategies to build a multi-tiered medical security system, highlighting the growing importance of commercial insurance as a supplement to public health insurance [5]. Group 3: Future Outlook - ZhongAn Online has served over 100 million users in the health insurance sector and aims to continue developing inclusive and differentiated health insurance products to enhance health security for families [5]. - The company plans to leverage its technological capabilities and business experience to contribute to the establishment of a multi-tiered medical security system in China [5].

Core Viewpoint - ZhongAn Online is actively participating in the "Medical Insurance + Commercial Insurance" integration pilot in Shanghai, aiming to enhance health insurance coverage and better serve the health management needs of insured individuals and their families [1][5]. Group 1: Product Offerings - The "Zhongminbao" series products, including "Zhongminbao Million Medical Insurance 2025" and "Zhongminbao Mid-to-High-End Medical Insurance," have been integrated into the Shanghai Medical Insurance personal account payment system [1]. - The "Zhongminbao" series features a core characteristic of "insurable and compensable with pre-existing conditions," targeting high-risk groups such as the elderly and those with health abnormalities, offering broader coverage compared to traditional million medical insurance [1][2]. - The "Zhongminbao Mid-to-High-End Medical Insurance" provides zero deductible for inpatient medical expenses and expands the scope of critical illness treatment claims to include special departments in public hospitals, catering to citizens' demand for quality medical resources [2]. Group 2: Policy and Market Impact - The integration of "Zhongminbao" into the medical insurance personal account payment system revitalizes dormant funds in personal accounts, transforming small amounts into significant health protection [2]. - The company supports insured individuals in using their personal account balances to cover family members, promoting a "family mutual aid" model with exclusive family rates [4]. - The ongoing emphasis on building a multi-tiered medical security system in China highlights the increasing supplementary role of commercial insurance, with ZhongAn Online having served over 100 million users in the health insurance sector [5].

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 06060 | 說明 | 眾安在綫 – H 股 | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 1,634,812,900 | RMB | | 1 RMB | | 1,634,812,900 | | 增加 / 減少 (-) | | | | | | RMB | | | | 本月底結存 | | | 1,634,812,900 | RMB | | 1 RMB | | 1,634,812,900 | | 2. 股份分類 | 普通股 | 股份類別 | 其他類別 (請註明) | | 於香港聯交所上市 (註1) | | ...